BIO-PATH HOLDINGS, INC. (BPTH)
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
Address
4710 BELLAIRE BOULEVARD
BELLAIRE, TX 77401
Founded
2007
Number of Employees
10
Website
http://www.biopathholdings.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)